000			02183nam a2200433 i 4500
999			_c273268 _d273268
001			on1045427728
003			OCoLC
005			20180815143559.0
007			he bmb024bbca
008			180723s2017 dcua bb f000 0 eng c
040			_aPUCPR _beng _erda _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a1033-A (MF)
086	0		_aY 4.AP 6/2:S.HRG.114-694
099			_aY 4.AP 6/2:S.HRG.114-694
110	1		_aUnited States. _bCongress. _bSenate. _bCommittee on Appropriations. _bSubcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies,
245	1	0	_aPrioritizing public health : _bthe FDA's role in the generic drug marketplace : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fourteenth Congress, second session : special hearing, September 21, 2016, Washington, DC.
246	3	0	_aFDA's role in the generic drug marketplace
246	3		_aFood and Drug Administration's role in the generic drug marketplace
264		1	_aWashington : _bU.S. Government Publishing Office, _c2017.
300			_aiii, 35 pages : _billustrations ; _c24 cm.
336			_btxt
337			_bh _2rdamedia
338			_bhe _2rdacarrier
490	1		_aS. hrg. ; _v114-694
500			_aShipping list no.: 2018-0117-M.
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
533			_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2018] _e1 microfiche : negative.
776	0	8	_iPrint version: _aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. _tPrioritizing public health _w(DLC) 2017434973 _w(OCoLC)1012108564
810	1		_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v114-694.
050		4	_aKF26 _b.A644 2016
610	1	0	_aUnited States. _bFood and Drug Administration _xRules and practice.
650		0	_aGeneric drugs _xGovernment policy _zUnited States.
650		0	_aDrugs _xPrices _zUnited States.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8